Eric K Rowinsky's Net Worth
$17.3 Million
Who is Eric K Rowinsky?
Eric K Rowinsky has an estimated net worth of $17.3 Million. This is based on reported shares across multiple companies, which include BIOGEN INC., BIND Therapeutics, Inc, Verastem, Inc., NEOPROBE CORP, Fortress Biotech, Inc., ADVENTRX PHARMACEUTICALS INC, STEMLINE THERAPEUTICS INC, TAPESTRY PHARMACEUTICALS, INC, and IMCLONE SYSTEMS INC/DE.
SEC CIK
Eric K Rowinsky's CIK is 0001318886
Past Insider Trading and Trends
2015 was Eric K Rowinsky's most active year for acquiring shares with 10 total transactions. Eric K Rowinsky's most active month to acquire stocks was the month of May. 2015 was Eric K Rowinsky's most active year for disposing of shares, totalling 10 transactions. Eric K Rowinsky's most active month to dispose stocks was the month of February. 2015 saw Eric K Rowinsky paying a total of $1,395,780.06 for 232,608 shares, this is the most they've acquired in one year. In 2015 Eric K Rowinsky cashed out on 59,130 shares for a total of $10,685,355.03, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
BIOGEN INC. (BIIB) Snapshot price: $200.5
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +6.50% | 1.34K |
—
|
—
| 21.97K |
Jun 21
| |||
Form 4
| +2.26% | 455 |
$222.54 | $101,255.70 | 20.63K |
Feb 15
| |||
Form 4
| +5.00% | 960 |
—
|
—
| 20.17K |
Jun 26
| |||
Form 4
| +7.68% | 1.37K |
—
|
—
| 19.21K |
Jun 15
| |||
Form 4
| +4.54% | 775 |
—
|
—
| 17.84K |
Jul 1
| |||
Form 4
| +5.50% | 890 |
—
|
—
| 17.07K |
Jun 3
| |||
Form 4
| +7.69% | 1.16K |
—
|
—
| 16.18K |
Jun 19
| |||
Form 4
| +6.22% | 880 |
—
|
—
| 15.02K |
Jun 12
| |||
Form 4
| +8.06% | 1.05K |
—
|
—
| 14.14K |
Jun 7
| |||
Form 4
| +8.83% | 1.06K |
—
|
—
| 13.06K |
Jun 8
| |||
Form 4
| +6.15% | 695 |
—
|
—
| 12.01K |
Jun 10
| |||
Form 4
|
—
|
0
|
$267.41 | -$4,843,905.06 | 11.31K |
Scheduled
|
Mar 20
| ||
Form 4
|
—
|
0
|
$247.98 | -$877,947.56 | 11.31K |
Scheduled
|
Mar 19
| ||
Form 4
|
—
|
0
|
$242.64 | -$1,706,409.21 | 11.31K |
Scheduled
|
Mar 17
| ||
Form 4
|
—
|
0
|
$238.53 | -$1,667,675.06 | 11.31K |
Scheduled
|
Mar 9
| ||
Form 4
| +8.33% | 870 |
—
|
—
| 11.31K |
Jun 12
| |||
Form 4
| -16.21% | -2.02K |
$310.09 | -$626,381.80 | 10.44K |
Scheduled
|
Jan 21
| ||
Form 4
| +11.70% | 1.3K |
—
|
—
| 12.46K |
Jun 12
| |||
Form 4
| +22.11% | 2.02K |
—
|
—
| 11.15K |
Jun 8
| |||
Form 4
|
—
|
0
|
$87.91 | -$729,890.56 | 9.13K |
Scheduled
|
Jan 6
| ||
Form 4
| +46.51% | 2.9K |
—
|
—
| 9.13K |
Jun 1
| |||
Form 4
| +1,147.00% | 5.74K |
—
|
—
| 6.24K |
Jun 9
| |||
Form 4
|
∞
| 500 |
—
|
—
| 500 |
Mar 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
BIND Therapeutics, Inc No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 15K |
$0.44 | $6,600.00 | 15K |
Aug 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Verastem, Inc. (VSTM) Snapshot price: $2.44
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 8.33K |
—
|
—
| 8.33K |
Jun 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 11
| |||
Form 4
|
∞
| 2K |
$3.84 | $7,680.00 | 2K |
Sep 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 15
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
May 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
NEOPROBE CORP (NAVB) Snapshot price: $0.0251
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Fortress Biotech, Inc. (FBIO) Snapshot price: $1.79
Vice Chairman the Board
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +10.73% | 6.67K |
—
|
—
| 68.8K |
Jan 1
| |||
Form 4
| +1.30% | 11.98K |
$0.84 | $9,999.96 | 931.98K |
Feb 10
| |||
Form 4
| +12.20% | 100K |
—
|
—
| 920K |
Jan 1
| |||
Form 4
| +13.89% | 100K |
—
|
—
| 820K |
Jan 1
| |||
Form 4
| +10.77% | 70K |
$4.24 | -$127,100.00 | 720K |
Jan 1 - Mar 2
| |||
Form 4
| +18.18% | 100K |
—
|
—
| 650K |
Jan 1
| |||
Form 4
| +22.22% | 100K |
—
|
—
| 550K |
Jan 1
| |||
Form 4
| +28.57% | 100K |
—
|
—
| 450K |
Jan 1
| |||
Form 4
| +40.00% | 100K |
—
|
—
| 350K |
Jan 1
| |||
Form 4
| +66.67% | 100K |
—
|
—
| 250K |
Jan 1
| |||
Form 4
| +66.67% | 100K |
—
|
—
| 250K |
Mar 12
| |||
Form 4
|
∞
| 50K |
—
|
—
| 50K |
Feb 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||